| BSE Code | Company | Start Date | Purpose |
|---|---|---|---|
| ATMAST | Atmastco Ltd Atmastco Ltd | 26-May-2026 | To consider and approve the financial results for the period ended March 31, 2026 |
| CLSL | Crop Life Scienc Crop Life Science Ltd | 26-May-2026 | To consider and approve the financial results for the period ended March 31, 2026 |
| DENTAL | Vasa Denticity Vasa Denticity Ltd | 26-May-2026 | To consider and approve the financial results for the period ended March 31, 2026 |
| 523736 | Dhunseri Vent. Dhunseri Ventures Ltd | 26-May-2026 | DHUNSERI VENTURES LIMITED has informed the Exchange about Board Meeting to be held on 26-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend |
| 523752 | Trans India Trans India House Impex Ltd | 26-May-2026 | Trans India House Impex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve 1. Audited Standalone and Consolidated Financial Results of the Company for the Quarter and the Financial Year ended 31st March 2026. 2. Any other matter with the permission of Chair. |
| 523792 | Mazda Mazda Ltd | 26-May-2026 | Mazda Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve the Audited Financial Results for the Fourth Quarter and Financial Year ended on 31st March 2026 and to recommend Final Dividend on equity shares if any. |
| 524156 | TCM TCM Ltd | 26-May-2026 | TCM Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve Notice is hereby given that a Meeting of the Board of Directors would be held on Tuesday 26th May 2026 at 10:30 A.M. at the Registered Office of the Company inter alia consider and approve: - 1. The Consolidated and Standalone Audited Financial Statements of the Company for the quarter and year ended 31st March 2026. 2. Any other matter with the permission of the Chair. Further in continuation of our intimation dated 27th March 2026 regarding closure of Trading Window we would like to re-iterate that the trading window shall re-open after 48 hours from the declaration of the financial results. We request you to take the information on record. Thanking you |
| 524404 | Marksans Pharma Marksans Pharma Ltd | 26-May-2026 | Marksans Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results and to consider recommendation of dividend if any, for the Financial Year ended March 31, 2026 |
| 524594 | Aeonx Digital Aeonx Digital Technology Ltd | 26-May-2026 | Aeonx Digital Technology Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve Enclosed |
| 524648 | Indo Amines Indo Amines Ltd | 26-May-2026 | Indo Amines Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve Please find enclosed herewith intimation regarding Board Meeting of the Company going to be held on Tuesday May 26 2026 to transact the following business: 1. To consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31 2026. 2. To consider and recommend a final dividend if any for the financial year ended March 31 2026. 3. Any other matter as the Board may deem fit. |
Old Backoffice
Data available till FY 2024-25 (Historical)
New Backoffice
Data From FY 2025-26 onwards (Latest)
